The Philadelphia market has gained recognition not only for its cell and gene therapy sector but also its real estate scene and talent pool. Vittoria Biotherapeutics, Interius BioTherapeutics and Chamber of Commerce for Greater Philadelphia executives share why the area is a life sciences hot spot.

As a life sciences hub within the Pharm Country hotbed, the Philadelphia market has much to offer, although it wasn’t always that way. Just ask Nick Siciliano, CEO, co-founder and director of Philadelphia-based Vittoria Biotherapeutics. He told BioSpace that Philadelphia’s life sciences scene has grown tremendously during his 20-year career in the city and is more sophisticated than it’s ever been.

“You have a stable of entrepreneurs and life science executives that I think are committed now to bringing Philadelphia up to par with the Bostons, the Bay Areas,” said Siciliano, whose clinical-stage immunotherapy company develops cell therapies for hard-to-treat diseases. “They’re committed to building companies here. The technology that we’ve seen just in the last decade has been inspirational coming out of some of these institutions for what I believe are going to be transformative modalities in medicine—cell therapy, gene therapy, etc.”

Read More